Green Alpha Advisors, LLC Crispr Therapeutics Ag Transaction History

Green Alpha Advisors, LLC

  • $78.9 Million
  • Q1 2025

A detailed history of Green Alpha Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 57,361 shares of CRSP stock, worth $2.68 Million. This represents 2.47% of its overall portfolio holdings.

Number of Shares
57,361
Previous 24,629 132.9%
Holding current value
$2.68 Million
Previous $969,000 101.34%
% of portfolio
2.47%
Previous 0.87%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 09, 2025
BUY
$34.03 - $53.02 $1.11 Million - $1.74 Million
32,732 Added 132.9%
57,361 $1.95 Million
Q4 2024

Jan 13, 2025
BUY
$38.65 - $55.15 $211,454 - $301,725
5,471 Added 28.56%
24,629 $969,000
Q3 2024

Oct 07, 2024
SELL
$44.62 - $62.75 $21,372 - $30,057
-479 Reduced 2.44%
19,158 $900,000
Q2 2024

Aug 13, 2024
SELL
$51.17 - $68.18 $374,513 - $499,009
-7,319 Reduced 27.15%
19,637 $1.06 Million
Q1 2024

Apr 09, 2024
BUY
$60.67 - $89.12 $145,972 - $214,422
2,406 Added 9.8%
26,956 $1.84 Million
Q4 2023

Jan 04, 2024
SELL
$38.62 - $72.18 $398,944 - $745,619
-10,330 Reduced 29.62%
24,550 $1.54 Million
Q3 2023

Oct 10, 2023
BUY
$45.39 - $59.0 $23,012 - $29,913
507 Added 1.47%
34,880 $1.58 Million
Q2 2023

Jul 06, 2023
BUY
$43.47 - $67.77 $77,811 - $121,308
1,790 Added 5.49%
34,373 $1.93 Million
Q1 2023

Apr 06, 2023
BUY
$41.0 - $56.12 $79,417 - $108,704
1,937 Added 6.32%
32,583 $1.47 Million
Q4 2022

Jan 12, 2023
BUY
$39.19 - $65.67 $124,624 - $208,830
3,180 Added 11.58%
30,646 $0
Q3 2022

Oct 14, 2022
SELL
$61.1 - $83.78 $12.3 Million - $16.8 Million
-200,820 Reduced 87.97%
27,466 $1.8 Million
Q2 2022

Jul 08, 2022
BUY
$43.23 - $73.83 $8.77 Million - $15 Million
202,753 Added 794.08%
228,286 $13.9 Million
Q1 2022

Apr 19, 2022
BUY
$53.19 - $79.24 $445,413 - $663,555
8,374 Added 48.8%
25,533 $1.6 Million
Q4 2021

Jan 12, 2022
BUY
$70.09 - $111.29 $156,791 - $248,955
2,237 Added 14.99%
17,159 $1.3 Million
Q3 2021

Oct 12, 2021
BUY
$110.2 - $156.64 $243,982 - $346,800
2,214 Added 17.42%
14,922 $1.67 Million
Q2 2021

Jul 22, 2021
BUY
$100.84 - $161.89 $596,367 - $957,417
5,914 Added 87.05%
12,708 $2.06 Million
Q1 2021

Jul 22, 2021
BUY
$110.72 - $210.04 $48,938 - $92,837
442 Added 6.96%
6,794 $828,000
Q4 2020

Jul 22, 2021
BUY
$79.67 - $173.23 $506,063 - $1.1 Million
6,352 New
6,352 $973,000

Others Institutions Holding CRSP

# of Institutions
480
Shares Held
64.2M
Call Options Held
2.15M
Put Options Held
1.92M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.65B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email